Antinociceptive and Anti-Inflammatory Activities of Acetonic Extract from Bougainvillea x buttiana (var. Rose)
Pharmaceuticals · 06.08.2024 · 17 (8) · 1037
DOI: 10.3390/ph17081037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 06.08.2024. Verfasst von Gabriela Castañeda-Corral und 5 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Universidad Autónoma del Estado de Morelos, Calle Iztaccihuatl Esq. Leñeros, Col. Volcanes, Cuernavaca 62350, Morelos, Mexico. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaria de Educación Pública (México).
Abstract (Originalsprache)
Background:Bougainvillea x buttiana is an ornamental plant with antioxidant, anti-inflammatory, and cytotoxic activities, which has been traditionally used to treat respiratory diseases. This study aimed to investigate whether the acetonic extract of Bougainvillea x buttiana var. Rose (BxbRAE-100%) has analgesic and anti-inflammatory properties and its potential action mechanisms.
Methods
Analgesic and anti-inflammatory activities were evaluated using three murine pain models and two acute inflammation models. In vitro, the ability of the extract to inhibit proteolytic activity and the activities of the enzymes phospholipase A2 (PLA2) and cyclooxygenase (COX) were evaluated. In silico analysis was performed to predict the physicochemical and Absorption, distribution, metabolism, and excretion (ADME) profiles of the compounds previously identified in BxbRAE-100%.
Results
In vivo BxbRAE-100% decreased the nociceptive behaviors in the writhing model, the tail immersion, and the formalin test, suggesting that the extract has the potential to relieve pain at peripheral and central levels. Additionally, topical or oral BxbRAE-100% treatment reduced dose-dependent 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced ear inflammation and carrageenan-induced paw edema, respectively. In vitro, BxbRAE-100% significantly inhibited proteolytic activity and PLA2, COX-1 and COX-2 activities. In silico, the compounds previously identified in BxbRAE-100% met Lipinski’s rule of five and showed adequate ADME properties.
Conclusions
These results support the use of B. x buttiana in Traditional Mexican Medicine and highlight its potential for the development of new treatments for pain and inflammation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Facultad de Medicina, Universidad Autónoma del Estado de Morelos, Calle Iztaccihuatl Esq. Leñeros, Col. Volcanes, Cuernavaca 62350, Morelos, Mexico.
ORCID-Profile: Mayra Cedillo-Cortezano, Misael López-Castillo, Juan José Acevedo-Fernández, Vera L Petricevich
Förderung
- Secretaria de Educación Pública (México)
Zitieren
APA
Castañeda-Corral, G., Cedillo-Cortezano, M., Aviles-Flores, M., López-Castillo, M., Acevedo-Fernández, J. J., & Petricevich, V. L. (2024). Antinociceptive and Anti-Inflammatory Activities of Acetonic Extract from Bougainvillea x buttiana (var. Rose). Pharmaceuticals, 17(8), 1037. https://doi.org/10.3390/ph17081037
Vancouver
Castañeda-Corral G, Cedillo-Cortezano M, Aviles-Flores M, López-Castillo M, Acevedo-Fernández JJ, Petricevich VL. Antinociceptive and Anti-Inflammatory Activities of Acetonic Extract from Bougainvillea x buttiana (var. Rose). Pharmaceuticals. 2024;17(8):1037. doi:10.3390/ph17081037
BibTeX
@article{CastaedaCorral2024,
author = {Castañeda-Corral, Gabriela and Cedillo-Cortezano, Mayra and Aviles-Flores, Magdalena and López-Castillo, Misael and Acevedo-Fernández, Juan José and Petricevich, Vera L},
title = {Antinociceptive and Anti-Inflammatory Activities of Acetonic Extract from Bougainvillea x buttiana (var. Rose)},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {8},
pages = {1037},
doi = {10.3390/ph17081037}
}
EUVIMED